Skip to main content
. 2024 Jul 12;110(10):6647–6657. doi: 10.1097/JS9.0000000000001813

Table 2.

Treatment-related adverse events and serious adverse events.

Adverse events Any grade Grade 1 Grade 2 Grade 3 Grade 4–5
Any 10 (100%) 8 (80%) 5 (50%) 3 (30%) 0
Hypertension 8 (80%) 8 (80%) 0 0 0
Elevated transaminases 6 (60%) 5 (50%) 1 (10%) 0 0
Diarrhea 5 (50%) 2 (20%) 2 (20%) 1 (10%) 0
Thrombocytopenia 5 (50%) 3 (30%) 2 (20%) 0 0
Elevated bilirubin 4 (40%) 3 (30%) 1 (10%) 0 0
Fatigue 3 (30%) 0 (0) 2 (20%) 1 (10%) 0
Pruritus 2 (20%) 0 1 (10%) 1 (10%) 0
Proteinuria 2 (20%) 0 2 (20%) 0 0
Neutropenia 2 (20%) 1 (10%) 1 (10%) 0 0
Pneumonitis 2 (20%) 1 (10%) 1 (10%) 0 0
Abdominal pain 2 (20%) 1 (10%) 1 (10%) 0 0
Elevated pancreatic enzymes 2 (10%) 2 (10%) 0 0 0
Elevated creatinine 2 (20%) 2 (20%) 0 0 0
Anemia 1 (10%) 1 (10%) 0 0 0

Data are n (%) and represent the highest grades assigned.